Thyroid Eye Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
It will take 2-3 business days to deliver the report upon receipt the order if any customization is not there.
Thyroid Eye Disease Trends and Forecast
The future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Thyroid Eye Disease by Segment
The study includes a forecast for the global thyroid eye disease by treatment type, route of administration, product, end use industry, and region.
Thyroid Eye Disease Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid eye disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid eye disease companies profiled in this report include-
Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
Within this market, hospitals will remain the largest segment.
APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.
Features of the Global Thyroid Eye Disease Market
Market Size Estimates: Thyroid Eye Disease Market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Thyroid Eye Disease Market by various segments, such as by treatment type, route of administration, product, end use industry and region in terms of($B).
Regional Analysis: Thyroid Eye Disease Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different treatment types, route of administrations, products, end use industries, and regions for the thyroid eye disease market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid eye disease market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the thyroid eye disease market size?
Answer: The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030.
Q.2 What is the growth forecast for thyroid eye disease market?
Answer: The global thyroid eye disease market is expected to grow with a CAGR of 8.1% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the thyroid eye disease market?
Answer: The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.
Q4. What are the major segments for thyroid eye disease market?
Answer: The future of the thyroid eye disease market looks promising with opportunities in the hospital and clinic markets.
Q5. Who are the key thyroid eye disease market companies?
Answer: Some of the key thyroid eye disease companies are as follows:
Answer: Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
Q7. In thyroid eye disease market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the thyroid eye disease market by treatment type (corticosteroids, vitamins, monoclonal antibody, and others), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to thyroid eye disease market or related to thyroid eye disease companies, thyroid eye disease market size, thyroid eye disease market share, thyroid eye disease market growth, thyroid eye disease market research, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
Thyroid Eye Disease Trends and Forecast
The future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Thyroid Eye Disease by Segment
The study includes a forecast for the global thyroid eye disease by treatment type, route of administration, product, end use industry, and region.
Thyroid Eye Disease Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:
- Corticosteroids
- Vitamins
- Monoclonal Antibody
- Others
- Oral
- Topical
- Parenteral
- Tablet
- Capsule
- Ointment
- Solution
- Hospitals
- Clinics
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid eye disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid eye disease companies profiled in this report include-
- Abbvie
- Novartis International
- Teva Pharmaceutical Industries
- Pfizer
- Sanofi S.A.
- Merck
- Abbot Laboratories
- Horizon Therapeutics
- Johnson & Johnson
- GE Healthcare
Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
Within this market, hospitals will remain the largest segment.
APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.
Features of the Global Thyroid Eye Disease Market
Market Size Estimates: Thyroid Eye Disease Market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Thyroid Eye Disease Market by various segments, such as by treatment type, route of administration, product, end use industry and region in terms of($B).
Regional Analysis: Thyroid Eye Disease Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different treatment types, route of administrations, products, end use industries, and regions for the thyroid eye disease market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid eye disease market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the thyroid eye disease market size?
Answer: The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030.
Q.2 What is the growth forecast for thyroid eye disease market?
Answer: The global thyroid eye disease market is expected to grow with a CAGR of 8.1% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the thyroid eye disease market?
Answer: The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.
Q4. What are the major segments for thyroid eye disease market?
Answer: The future of the thyroid eye disease market looks promising with opportunities in the hospital and clinic markets.
Q5. Who are the key thyroid eye disease market companies?
Answer: Some of the key thyroid eye disease companies are as follows:
- AbbVie
- Novartis International
- Teva Pharmaceutical Industries
- Pfizer
- Sanofi S.A.
- Merck
- Abbot Laboratories
- Horizon Therapeutics
- Johnson & Johnson
- GE Healthcare
Answer: Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
Q7. In thyroid eye disease market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the thyroid eye disease market by treatment type (corticosteroids, vitamins, monoclonal antibody, and others), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to thyroid eye disease market or related to thyroid eye disease companies, thyroid eye disease market size, thyroid eye disease market share, thyroid eye disease market growth, thyroid eye disease market research, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL THYROID EYE DISEASE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Thyroid Eye Disease Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Thyroid Eye Disease Market by Treatment Type
3.3.1: Corticosteroids
3.3.2: Vitamins
3.3.3: Monoclonal Antibody
3.3.4: Others
3.4: Global Thyroid Eye Disease Market by Route of Administration
3.4.1: Oral
3.4.2: Topical
3.4.3: Parenteral
3.5: Global Thyroid Eye Disease Market by Product
3.5.1: Tablet
3.5.2: Capsule
3.5.3: Ointment
3.5.4: Solution
3.6: Global Thyroid Eye Disease Market by End Use Industry
3.6.1: Hospitals
3.6.2: Clinics
3.6.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Thyroid Eye Disease Market by Region
4.2: North American Thyroid Eye Disease Market
4.2.1: North American Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.2.2: North American Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.3: European Thyroid Eye Disease Market
4.3.1: European Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.3.2: European Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.4: APAC Thyroid Eye Disease Market
4.4.1: APAC Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.4.2: APAC Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.5: ROW Thyroid Eye Disease Market
4.5.1: ROW Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.5.2: ROW Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Thyroid Eye Disease Market by Treatment Type
6.1.2: Growth Opportunities for the Global Thyroid Eye Disease Market by Route of Administration
6.1.3: Growth Opportunities for the Global Thyroid Eye Disease Market by Product
6.1.4: Growth Opportunities for the Global Thyroid Eye Disease Market by End Use Industry
6.1.5: Growth Opportunities for the Global Thyroid Eye Disease Market by Region
6.2: Emerging Trends in the Global Thyroid Eye Disease Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Thyroid Eye Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Eye Disease Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: AbbVie
7.2: Novartis International
7.3: Teva Pharmaceutical Industries
7.4: Pfizer
7.5: Sanofi S.A.
7.6: Merck
7.7: Abbot Laboratories
7.8: Horizon Therapeutics
7.9: Johnson & Johnson
7.10: GE Healthcare
2. GLOBAL THYROID EYE DISEASE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Thyroid Eye Disease Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Thyroid Eye Disease Market by Treatment Type
3.3.1: Corticosteroids
3.3.2: Vitamins
3.3.3: Monoclonal Antibody
3.3.4: Others
3.4: Global Thyroid Eye Disease Market by Route of Administration
3.4.1: Oral
3.4.2: Topical
3.4.3: Parenteral
3.5: Global Thyroid Eye Disease Market by Product
3.5.1: Tablet
3.5.2: Capsule
3.5.3: Ointment
3.5.4: Solution
3.6: Global Thyroid Eye Disease Market by End Use Industry
3.6.1: Hospitals
3.6.2: Clinics
3.6.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Thyroid Eye Disease Market by Region
4.2: North American Thyroid Eye Disease Market
4.2.1: North American Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.2.2: North American Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.3: European Thyroid Eye Disease Market
4.3.1: European Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.3.2: European Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.4: APAC Thyroid Eye Disease Market
4.4.1: APAC Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.4.2: APAC Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
4.5: ROW Thyroid Eye Disease Market
4.5.1: ROW Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
4.5.2: ROW Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Thyroid Eye Disease Market by Treatment Type
6.1.2: Growth Opportunities for the Global Thyroid Eye Disease Market by Route of Administration
6.1.3: Growth Opportunities for the Global Thyroid Eye Disease Market by Product
6.1.4: Growth Opportunities for the Global Thyroid Eye Disease Market by End Use Industry
6.1.5: Growth Opportunities for the Global Thyroid Eye Disease Market by Region
6.2: Emerging Trends in the Global Thyroid Eye Disease Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Thyroid Eye Disease Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Eye Disease Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: AbbVie
7.2: Novartis International
7.3: Teva Pharmaceutical Industries
7.4: Pfizer
7.5: Sanofi S.A.
7.6: Merck
7.7: Abbot Laboratories
7.8: Horizon Therapeutics
7.9: Johnson & Johnson
7.10: GE Healthcare
